Hostname: page-component-84b7d79bbc-dwq4g Total loading time: 0 Render date: 2024-07-27T17:43:52.306Z Has data issue: false hasContentIssue false
  • English
  • Français

Familial Subsets in Idiopathic Parkinson’s Disease

Published online by Cambridge University Press:  18 September 2015

André Barbeau  and
Madeleine Roy
Madeleine Roy
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In the present paper we explore in some detail the hypothesis that the presence of familial aggregations in 10–15% of Parkinson’s disease cases is due in great part to the existence of well-defined familial subsets, rather than to chance occurrences. We describe the clinical and genetic characteristics of the two main subsets: “Essential tremor-related Parkinsonism” and the “Familial akineto-rigid Syndrome” previously identified.

The former type of Parkinsonism is associated at random, but with increased frequency, to an autosomal dominant disorder, usually essential tremor but occasionally OPCA. Two possible susceptibility factors were uncovered in this entity: an increased incidence of familial hyperthyroidism (augmentor factor) and a decreased incidence of the generally frequent HLA Haplotypes A1B8 or A2B5 (Protective factors).

The other presentation, the “familial akineto-rigid syndrome”, appears to be a definite disease entity with an autosomal recessive mode of inheritance (normal parents, increased incidence of identical parkinsonism in sibs, increased consanguinity rate in parents). This newly defined disorder deserves much further genetic and biochemical analysis.

Type
3. Genetic Factors and Epidemiology of Parkinson’s Disease
Information
Canadian Journal of Neurological Sciences , Volume 11 , Issue S1: Current Concepts and Controversies in Parkinson’s Disease , February 1984 , pp. 144 - 150
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Barbeau, A (1973) Aging and the extrapyramidal system. J Amer Geriat. Soc. 21:145–149.CrossRefGoogle ScholarPubMed
Barbeau, A, Pourcher, E (1982) New data on the genetics of Parkinson’s disease. Can J Neurol Sci 9:53–60.CrossRefGoogle ScholarPubMed
Dawidovitz, S, Zamur, R, Kott, E (1977) HLA antigens in Parkinson’s disease. In: Den Hartog Jager, WA; Bruyn, GW, Heijstee, APJ. Eds 11th World congress of Neurology, Excerpta Medica, Amsterdam, p. 126.Google Scholar
Duvoisin, RC, Gearing, FR, Schweitzer, MD, Yahr, MD (1969) A family study of Parkinsonism. In: Progress in neuro-genetics (Eds. Barbeau, A., Brunette, J.R.) Excerpta Medica. Foundation, Amsterdam, pp 492–296.Google Scholar
Eeg-Olofsson, O, Säfwenberg, J, Wigertz, A (1982) HLA and Epilepsy: an investigation of different types of epilepsy in children and their families. Epilepsia 23:27–34.CrossRefGoogle ScholarPubMed
Elizan, TS, Terasaki, PI, Yahr, MD (1980) HLA-B14 antigen and postencephalitic Parkinson’s disease–Theirassociation inan American-Jewish ethnic group. Arch Neurol 37:542–544.CrossRefGoogle Scholar
Emile, J, Truelle, JL, Pouplard, A, Hurez, D (1977) Association maladie de Parkinson-antigènes HLA-B17 et B18. La Nouv Presse Méd 6:4144. Kessler, II (1978) “Parkinson’s disease in epidemiologic perspective”. Advances in Neurology 19:355–384.Google Scholar
Kondo, K, Kurland, LT, Schull, WJ (1973) Parkinson’s disease. Genetic analysis and evidence of a multifactorial etiology. Mayo Clinic Proc. 48:465–475.Google ScholarPubMed
Konigsmark, B, Weiner, L (1970) The olivo-ponto-cerebellar atrophies: a review. Medicine 49:227–241.CrossRefGoogle Scholar
Kurland, LT (1958) Epidemiology: incidence, geographic distribution and genetic considerations. In: “Pathogenesis and Treatment of Parkinsonism” (Ed Fields, WS) Charles C Thomas, Springfield pp 5–49.Google Scholar
Laberge, C (1966) Prospectus for genetic studies in the French Canadians, with preliminary data on blood groups and consanguinity. Bull Johns Hopkins Hosp 118:52–68.Google Scholar
Lees, AJ, Stern, GM, Compston, DAS (1982) Histocompatibility antigens and post-encephalitic Parkinsonism. J Neurol Neurosurg Psychiatr 45:1060–1061.CrossRefGoogle ScholarPubMed
Leheny, WA, Davidson, DLW, De Vane, P, House, AO, Lenman, JAR (1983) HLA antigens in Parkinson’s disease. Tissue Antigens 21:260–261.CrossRefGoogle ScholarPubMed
Madigand, M, Oger, JJF, Fauchet, R, Sabouraud, O, Genetet, B (1982) HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J. Neurol Sci 53:519–529.CrossRefGoogle ScholarPubMed
Martilla, RJ, Rinne, UK, Thlikainen, A (1981) Histocompatibility types in Parkinson’s disease. J Neurol Sci 51:217–221.CrossRefGoogle Scholar
Martin, WE, Young, WI, Anderson, VE (1973) Parkinson’s disease – a genetic study. Brain 96:495–506.CrossRefGoogle ScholarPubMed
Mjönes, H (1949) Paralysis agitans: a clinical and genetic study. Acta Psychiat. Scand., Suppl. 54, p. 1. Munksgaard, Copenhagen.Google Scholar
Perry, TL, Bratty, PJA, Hansen, S, Kennedy, J, Urquhart, N, Dolman, EL (1975) Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol 32:108–113.CrossRefGoogle ScholarPubMed
Plaitakis, A, Berl, S, Yahr, MD (1983) Evidence of mutation of a glutamate dehydrogenase ‘Isoenzyme’ in recessive olivoponto cerebellar atrophy. Ann Neurol 14:108–109.Google Scholar
Purdy, A, Hahn, A, Barnett, HJM, Bratty, P, Ahmad, D, Lloyd, KG, McGeer, EG, Perry, TL (1979) Familial fatal Parkinson with alveolar hypoventilation and mental depression. Ann Neurol 6:523–531.CrossRefGoogle ScholarPubMed
Reed, E, Lewison, A, Mayeaux, R, Suciu-Foca, N (1983) HLA antigens in Parkinson’s disease. Tissue Antigens 21:161–163.CrossRefGoogle ScholarPubMed
Roy, M, Boyer, L, Barbeau, A (1983) A Prospective study of 50 cases of familial Parkinson’s disease. Can J Neurol Sci 10:37–42.CrossRefGoogle ScholarPubMed
Svejgaard, A, Staub-Nielsen, I, Bodmer, WF (1974) HLA antigens and disease. Statistical and genetical considerations. Tissue Antigens 4:95–105.CrossRefGoogle ScholarPubMed
Takagi, S, Shinohara, Y, Tsuji, K (1982) Histocompatibility antigens in Parkinson’s disease. Acta Neurol Scandinav 66:590–593.CrossRefGoogle ScholarPubMed
Ward, CD, Duvoisin, RC, Ince, SE, Nutt, JD, Eldridge, R, Calne, DB (1983) Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology (Cleveland) 33:815–824.CrossRefGoogle Scholar
Wastiaux, JP, Lamoureux, G, Bouchard, JP, Durivage, A, Barbeau, C, Barbeau, A (1978) HLA and complement typing in olivo-ponto-cerebellar atrophy. Can J Neurol Sci 5:75–81.CrossRefGoogle ScholarPubMed
Yokochi, M, Narabayashi, H (1981) Clinical characteristics in Juvenile Parkinsonism. In: Research Progress in Parkinson’s disease (Clifford Rose, F, Capildeo, R, Eds) Pitman Medical, Turnbridge Wells, pp 35–39.Google Scholar